Sun, Sep 21, 2014, 5:35 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Questcor Pharmaceuticals, Inc. (QCOR) Message Board

  • holidayinnandout holidayinnandout Jun 25, 2013 11:18 AM Flag

    QCOR Best-Run Biotech Company

    per drdonrs message on 6-23
    #1... Questcor Pharmaceuticals (NASDAQ: QCOR )
    The No. 1 spot belongs to Questcor. The biotech's one-year ROIC is a whopping 85.19%. Over the last five years, Questcor's average ROIC stands at 55.8%. That's quite impressive.

    Questcor's earnings soared by 47% over the last year. The company grew trailing 12-month earnings by 375% during the past five years.

    While controversy swirls around Questcor's ability to sustain these levels, there's no question that its management team has executed exceptionally well. The biotech bought Acthar gel from Aventis in 2001. Don Bailey joined Questcor as CEO in 2007 and led the effort to reposition Acthar as a drug used in the treatment of orphan diseases, including multiple sclerosis, infantile spasms and nephrotic syndrome. Questcor has since been named America's No. 1 small company by Forbes and received the 2012 Corporate Citizenship Award from the Child Neurology Foundation.

    Sentiment: Strong Buy

 
QCOR
93.600.00(0.00%)Aug 14 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.